This brand name is authorized in Finland, France, Ireland.
The drug SOLUPRICK contains one active pharmaceutical ingredient (API):
1
|
UNII
3POA0Q644U - HISTAMINE DIHYDROCHLORIDE
|
|
Histamine/IL-2 is an immunotherapy which aims to induce immune-mediated destruction of residual myeloid leukaemic cells and thereby to prevent relapse of leukaemia. The role of histamine is to protect lymphocytes, in particular NK cells and T cells, which are responsible for the immune-mediated destruction of residual leukaemic cells. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| V01AA02 | Grass pollen | V Various → V01 Allergens → V01A Allergens → V01AA Allergen extracts |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| FI | Lääkealan turvallisuus- ja kehittämiskeskus | 024603, 024681 |
| FR | Base de données publique des médicaments | 61707652 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.